logxact program cytel studio version 6.3.0 (Cytel Inc)
90
Structured Review
Cytel Inc
logxact program cytel studio version 6.3.0
Logxact Program Cytel Studio Version 6.3.0, supplied by Cytel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/logxact+program+cytel+studio+version+6%2E3%2E0/logxact+program+cytel+studio+version+6+3+0/10__1200_slash_jco__2006__10__4521-92-39-43
Average 90 stars, based on 1 article reviews
Logxact Program Cytel Studio Version 6.3.0, supplied by Cytel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/logxact+program+cytel+studio+version+6%2E3%2E0/logxact+program+cytel+studio+version+6+3+0/10__1200_slash_jco__2006__10__4521-92-39-43
Average 90 stars, based on 1 article reviews
logxact program cytel studio version 6.3.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Phase II Study of Uracil-Tegafur With Leucovorin in Elderly (≥ 75 years old) Patients With Colorectal Cancer: ECOG 1299 Article Snippet: Purpose To evaluate the tolerability and effectiveness of uracil-tegafur (UFT) with leucovorin (LV) in the treatment of elderly patients with advanced colorectal cancer.. Patients and Methods Patients 75 years of age with previously untreated colorectal cancer were eligible for this phase II, single-arm, open-label, multicenter cooperative group clinical trial.. UFT 100 mg/m plus LV 30 mg orally every 8 hours for 28 days every 35 days was administered until progression. |